10x Genomics, Inc. TXG Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $150.84M-2.6% | $166.03M+0.6% | $149M-1.7% | $172.91M+12.9% | $154.88M+9.8% | ||
| $44.67M-9.7% | $52.99M-2.0% | $48.7M+7.6% | $47.82M-2.2% | $49.44M+2.8% | ||
| $106.18M+0.7% | $113.05M+1.9% | $100.31M-5.7% | $125.08M+20.0% | $105.45M+13.5% | ||
| 70.4%+2.3pp | 68.1%+0.9pp | 67.3%-2.8pp | 72.3%+4.3pp | 68.1%+2.2pp | ||
| $56.85M-11.5% | $55.97M-16.4% | $57.19M-13.6% | $61.22M-2.7% | $64.25M-6.4% | ||
| $66.38M-26.0% | $76.62M-18.3% | $75.36M-7.8% | $74.43M-10.4% | $89.73M+4.6% | ||
| $123.22M-14.9% | $132.59M-17.5% | $132.55M-10.4% | $94.96M-34.9% | $144.77M-6.2% | ||
| $123.22M-14.9% | $132.59M-17.5% | $132.55M-10.4% | $94.96M-34.9% | $144.77M-6.2% | ||
| -$17.05M+56.7% | -$19.54M+60.8% | -$32.24M+22.3% | $30.13M+172% | -$39.33M+36.0% | ||
| -11.3%+14.1pp | -11.8%+18.4pp | -21.6%+5.7pp | 17.4%+44.7pp | -25.4%+18.2pp | ||
| $5.01M+36.0% | $6.89M+52.9% | $5.2M+4.6% | $4.27M-9.4% | $3.69M-22.2% | ||
| $4.2M-27.9% | $4.35M+198% | $4.04M-42.7% | $6.87M+47.5% | $5.82M+57.6% | ||
| -$12.85M+61.7% | -$15.19M+68.6% | -$28.21M+18.1% | $37M+200% | -$33.51M+42.0% | ||
| $623K-26.9% | $1.06M+63.4% | -$733K-156% | $2.46M+201% | $852K-60.3% | ||
| -$13.47M+60.8% | -$16.25M+66.9% | -$27.47M+23.2% | $34.54M+191% | -$34.36M+42.7% | ||
| -8.9%+13.3pp | -9.8%+19.9pp | -18.4%+5.1pp | 20%+44.7pp | -22.2%+20.3pp | ||
| -$0.10+64.3% | -$0.13+68.3% | -$0.22+26.7% | $0.28+188% | -$0.28+44.0% | ||
| -$0.10+64.3% | -$0.13+68.3% | -$0.22+26.7% | $0.28+188% | -$0.28+44.0% | ||
| 128.3M+4.6% | 124.7M+3.6% | 125.5M+4.0% | 124.5M+3.7% | 122.6M+2.7% | ||
| 128.3M+4.6% | 124.7M+3.6% | 125.5M+4.0% | 123.8M+3.1% | 122.6M+2.7% | ||
| $0-100% | $0— | $0— | $40.7M— | $9.2M— | ||
| -$815K-138% | —— | -$1.17M-156% | $2.6M+4,748% | $2.14M+305% | ||
| $56.85M-11.5% | $55.97M-16.4% | $57.19M-13.6% | $61.22M-2.7% | $64.25M-6.4% | ||
| $150.84M-2.6% | $166.03M+0.6% | $149M-1.7% | $172.91M+12.9% | $154.88M+9.8% | ||
| -$17.05M+56.7% | -$19.54M+60.8% | -$32.24M+22.3% | $30.13M+172% | -$39.33M+36.0% | ||
| -$7.09M+77.4% | -$9.48M+76.9% | -$21.95M+32.5% | $37.94M+216% | -$31.31M+40.1% | ||
| -$7.09M+77.4% | -$9.48M+76.9% | -$21.95M+32.5% | $37.94M+216% | -$31.31M+40.1% | ||
| -4.7%+15.5pp | -5.7%+19.2pp | -14.7%+6.7pp | 21.9%+43.3pp | -20.2%+16.9pp | ||
| -$17.05M+56.7% | -$19.54M+60.8% | -$32.24M+22.3% | $30.13M+172% | -$39.33M+36.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are 10x Genomics, Inc.'s profit margins?
- Gross margin is 69.6% and operating margin is -6.1%, with a -3.5% net margin.
- Where does 10x Genomics, Inc.'s income statement data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.